SAN FRANCISCO, Sept. 28, 2022 (GLOBE NEWSWIRE) — Hagens Berman is urging Coupang, Inc. CPNG Investors who bought shares as part of the company’s IPO
SAN DIEGO, Sept. 28, 2022 (GLOBE NEWSWIRE) — The class: Law firm for shareholder rights Robbins LLP reminds investors that a shareholder on behalf of
SOUTH SAN FRANCISCO, Calif., September 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. ALGSA clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to
NEW YORK, September 28, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) investigates claims on behalf of investors of Olo Inc. (“Olo” or
NEW YORK, September 28, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Olo Inc. (“Olo”
EDMONTON, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) — The Alberta Provincial Court has outlined the specific steps it is taking to provide a culturally relevant,
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”)
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”)
OAK RIDGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) — Lakeland Bank (“Lakeland”), the wholly owned subsidiary of Lakeland Bancorp, Inc., announced today that it has
SAN FRANCISCO, Sept. 28, 2022 (GLOBE NEWSWIRE) — Hagens Berman is urging Coupang, Inc. CPNG Investors who bought shares as part of the company’s IPO
SAN DIEGO, Sept. 28, 2022 (GLOBE NEWSWIRE) — The class: Law firm for shareholder rights Robbins LLP reminds investors that a shareholder on behalf of
SOUTH SAN FRANCISCO, Calif., September 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. ALGSA clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to
NEW YORK, September 28, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) investigates claims on behalf of investors of Olo Inc. (“Olo” or
NEW YORK, September 28, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Olo Inc. (“Olo”
EDMONTON, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) — The Alberta Provincial Court has outlined the specific steps it is taking to provide a culturally relevant,
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”)
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”)
OAK RIDGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) — Lakeland Bank (“Lakeland”), the wholly owned subsidiary of Lakeland Bancorp, Inc., announced today that it has
